JL

Jian Luo

NB Ngm Biopharmaceuticals: 13 patents #6 of 43Top 15%
ME Metabolex: 8 patents #6 of 50Top 15%
SP Shaman Pharmaceuticals: 6 patents #2 of 29Top 7%
Stanford University: 4 patents #598 of 5,197Top 15%
DC Diatex Co.: 4 patents #1 of 25Top 4%
AM Amgen: 3 patents #987 of 2,867Top 35%
DA Department Of Veterans Affairs: 1 patents #199 of 615Top 35%
CU Columbia University: 1 patents #1,151 of 2,492Top 50%
FU Fitel Usa: 1 patents #112 of 266Top 45%
📍 Albany, CA: #14 of 590 inventorsTop 3%
🗺 California: #12,236 of 386,348 inventorsTop 4%
Overall (All Time): #85,768 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 26–38 of 38 patents

Patent #TitleCo-InventorsDate
7576131 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Kenneth L. Luskey 2009-08-18
7241743 Sir2α-based therapeutic and prophylactic methods Wei Gu 2007-07-10
6779930 Systems and methods for improving reproducibility of splice loss reduction in a pre-splice heat treatment Harish C. Chandan 2004-08-24
6646004 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia Kenneth L. Luskey 2003-11-11
6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Kenneth L. Luskey, Zuchun Zhao 2003-09-23
6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Kenneth L. Luskey 2003-09-02
6262118 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia Kenneth L. Luskey 2001-07-17
5837255 Method of reducing blood glucose by administering Harunganin or Vismin Wayne D. Inman 1998-11-17
5827898 Use of bisphenolic compounds to treat type II diabetes Atul S. Khandwala 1998-10-27
5747527 Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes Wayne D. Inman, Steven Row King, Joseph L. Evans 1998-05-05
5674900 Terpenoid-type quinones for treatment of diabetes Rosa Ubillas, Jolad D. Shivanand, Christopher D. Mendez, Diana M. Fort, Joseph L. Evans 1997-10-07
5628999 Hypoglycemic agent from cryptolepis Diana M. Fort, Donald Bierer, Reimar Bruening, Steven Row King, Thomas J. Carlson 1997-05-13
5629319 Hypoglycemic agent from cryptolepis Diana M. Fort, Donald Bierer, Reimar Bruening 1997-05-13